Patents by Inventor CFD Research Corporation

CFD Research Corporation has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130149735
    Abstract: Methods of assaying the leukocyte adhesion cascade (LAC) and monitoring leukocyte rolling, adhesion, and/or migration can be implemented with an apparatus that includes an idealized microvascular network (IMN) of one or more interconnected idealized flow channels in fluid communication through a porous wall with a tissue space (e.g., idealized tissue space). The methods of assaying the LAC can be implemented with means for quantifying modulation of the leukocyte adhesion cascade. Methods of assaying the LAC can be implemented with the device and one or more active agents to monitor leukocyte rolling, adhesion, and/or migration in the presence of absence of the active agent. Migration can be through the idealized flow channels, through the porous wall, and/or into the tissue space.
    Type: Application
    Filed: January 16, 2013
    Publication date: June 13, 2013
    Applicant: CFD RESEARCH CORPORATION
    Inventor: CFD Research Corporation
  • Publication number: 20130133242
    Abstract: A group of tertiary amine azides are useful as hypergolic fuels for hypergolic bipropellant mixtures. The fuels provide higher density impulses than monomethyl hydrazine (MMH) but are less toxic and have lower vapor pressures that MMH. In addition, the fuels have shorter ignition delay times than dimethylaminoethylazide (DMAZ) and other potential reduced toxicity replacements for MMH.
    Type: Application
    Filed: January 23, 2013
    Publication date: May 30, 2013
    Applicant: CFD RESEARCH CORPORATION
    Inventor: CFD Research Corporation
  • Publication number: 20130101991
    Abstract: An apparatus for assaying a tumor drug delivery vehicle and or drug can include an idealized microvascular network (IMN) of one or more interconnected idealized flow channels in fluid communication through a porous wall with a tissue space (e.g., idealized tissue space) containing animal cells and means for quantifying drug delivery through the IMN to the animal cells.
    Type: Application
    Filed: December 14, 2012
    Publication date: April 25, 2013
    Applicant: CFD Research Corporation
    Inventor: CFD Research Corporation